+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Clinical Microbiology Market by Product, by Application, By End User, by Region, Industry Insights, Market Share, Competitive Analysis and Trends and Future Forecast 2020- 2027

  • PDF Icon


  • 182 Pages
  • January 2020
  • Region: Global
  • Blueweave Consulting & Research Pvt Ltd
  • ID: 5271474

According to this report, the global clinical microbiological market size was calculated to be USD 9.1 billion in 2016. The rise in the infectious disease is expected to drive the market along with the subsidizing of the social insurance offered by various organizations and government. Ineluctable ailment expanding with every passing time demanding expenditure, funding, and research allotment will inevitably spur the market scenario.

Better adaptations of end user products for technological advancement will upsurge the market scenario

With the technological advancement, molecular diagnostic techniques help in early identification and effectual treatment. This advanced molecular diagnostic methodology infers sharper sample throughput, brisk turnaround time, specificity, improved accuracy and multiplicity of reaction. NGS, molecular cartridges, real time PCR and PCR coupled with mass spectrometry are such advanced molecular diagnostic techniques which increase the capabilities in analyzing multiple samples in a single input. This identification and characterization of molecules and pathogens allow adaptation of products among key end users including healthcare providers, pharmaceuticals and biotechnology organization and research laboratories. This will implement an aura of expansion of clinical biological market on a global level.

Governmental norms and policies for prioritizing healthcare infrastructure in developing nations

Governments across the world, specifically in emerging countries will offer a diverse opportunity to the clinical biological market. Significant growth opportunities can be attributed to the upsurging ubiquity in maladies like malaria, influenza, tuberculosis, and HIV along with various other genomic efficient disease. Research and development initiatives by developing nations to improvise the healthcare infrastructure, healthcare expenditure and availability of cost efficient clinical microbiological products will help in strengthen the market growth parameters.

North America to lead the global market along with Asian countries during the forecasted period

In 2016, North America registered the highest revenue share in the global market followed by Europe. Adoption of advanced diagnostic techniques in U.S. are a result of developed industrial and healthcare sectors in the country. Apart from this, a stringent regulatory framework and working methodology of leading payers are inflating the regional market growth. Between 2016 to 2024, Asia Pacific is expected to register a fast-paced growth with Japan leading in the arena. Strong technological developments and high usage of microbial testing in various segments are widening the clinical microbiology market in Japan. With a surge in medical tourism in Asian Countries like India, China, Thailand, and Malaysia a demand for microbial diagnostic and monitoring tests in increasing with China contributing to the regional market growth. Also, skilled labors at affordable costs and advanced manufacturing infrastructure are driving the major pharmaceutical and medical devices companies to focus more on Asia.

The key players in the Global Clinical Microbiology Market includes, BioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US) and other prominent players are expanding their presence in the market by implementing various business strategies.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Clinical Microbiology Market market size & forecast. The report promises to provide recent technology trends of the Global Clinical Microbiology Market and industry insights that help decision-makers to make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

This product will be delivered within 2 business days.

Table of Contents

1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Clinical Microbiology Market Insights
4.1. DROC Analysis
4.1.1. Growth Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Recent Development
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Intensity of Rivalry
4.4. Impact of Covid-19 on Clinical Microbiology Market Industry.
5. Global Clinical Microbiology Market Overview
5.1. Market Size & Forecast by Value, 2020-2027
5.1.1. By Value (USD Million)
5.1.2. By Volume (Million Unit)
5.2. Market Share & Forecast
5.2.1. By Product Channel Laboratory Instruments Incubators Gram Stainers Bacterial Colony Counters Autoclave Sterilizers Petri Dish Fillers Automated Culture Systems Microbiology Analyzers Molecular Diagnostic Instruments Microscopes Mass Spectrometers Reagents
5.2.2. Application Outlook Respiratory Diseases Bloodstream Infections Gastrointestinal Diseases Sexually Transmitted Diseases Urinary Tract Infections Periodontal Diseases Other Diseases
5.2.3. By Region North America Europe Asia Pacific Latin America Middle East & Africa
6. North America Clinical Microbiology Market
6.1. Market Size & Forecast by Value, 2020-2027
6.1.1. By Value (USD Million)
6.1.2. By Volume (Million Unit)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By Country United States Canada
7. Europe Clinical Microbiology Market
7.1. Market Size & Forecast by Value, 2020-2027
7.1.1. By Value (USD Million)
7.1.2. By Volume (Million Unit)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Country Germany Poland Russia Italy France United Kingdom Spain Rest of Europe
8. Asia Pacific Clinical Microbiology Market
8.1. Market Size & Forecast by Value, 2020-2027
8.1.1. By Value (USD Million)
8.1.2. By Volume (Million Unit)
8.2. Market Share & Forecast
8.2.1. By Products
8.2.2. By Application
8.2.3. By Country China India Japan Malaysia Singapore Rest of Asia Pacific
9. Latin America Clinical Microbiology Market
9.1. Market Size & Forecast by Value, 2020-2027
9.1.1. By Value (USD Million)
9.1.2. By Volume (Million Unit)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Country Brazil Mexico Rest of Latin America
10. Middle East & Africa Clinical Microbiology Market
10.1. Market Size & Forecast by Value, 2020-2027
10.1.1. By Value (USD Million)
10.1.2. By Volume (Million Unit)
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Country Saudi Arabia GCC UAE South Africa Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market/Ranking Share Analysis
11.3. Competitive Benchmarking, By Operating Parameters
12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
12.1. BioMérieux (France),
12.2. Danaher Corporation (US),
12.3. Becton Dickinson and Company (US),
12.4. Abbott Laboratories (US),
12.5. Roche Diagnostics (Switzerland),
12.6. Thermo Fisher Scientific (US),
12.7. QIAGEN (Netherlands),
12.8. 3M (US),
12.9. Bio-Rad Laboratories (US),
12.10. Bruker Corporation (US),
12.11. Hologic (US)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • BioMérieux (France)
  • Danaher Corporation (US)
  • Becton
  • Dickinson and Company (US)
  • Abbott Laboratories (US)
  • Roche Diagnostics (Switzerland)
  • Thermo Fisher Scientific (US)
  • QIAGEN (Netherlands)
  • 3M (US)
  • Bio-Rad Laboratories (US)
  • Bruker Corporation (US)
  • Hologic (US)